ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,634.61
      1.15%
      US Tech 100
      19,202.80
      1.10%
      Dow Jones
      41,175.08
      1.14%
      Brent Oil
      78.375
      0.00%
      Bitcoin
      64,180.22
      0.02%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. Europe
      5. EU

      6. Cellectis Nom Eo 05 (ALCLS) Quote

      Cellectis Nom Eo 05

      Cellectis Nom Eo 05 (ALCLS)

      EU
      2.06
      0.04
      (1.98%)
      Closed August 25 11:30AM
      Delayed by 15 minutes

      Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

      Premium

      Key stats and details

      Current Price
      2.06
      Bid
      1.952
      Ask
      2.10
      Volume
      26,879
      1.96 Day's Range 2.06
      0.888 52 Week Range 3.44
      Market Cap
      94.502M
      Previous Close
      2.02
      Open
      2.00
      Last Trade
      20
      @
      2.06
      Last Trade Time
      Financial Volume
      -
      VWAP
      -
      Average Volume (3m)
      74,868
      Shares Outstanding
      45,874,895
      Dividend Yield
      -
      PE Ratio
      -1.15
      Earnings Per Share (EPS)
      -2.2
      Revenue
      9.24M
      Net Profit
      -101.06M

      About Cellectis Nom Eo 05

      Sector
      Pharmaceutical Preparations
      Industry
      Pharmaceutical Preparations
      Website
      www.cellectis.com
      Headquarters
      Paris, Paris, Fra
      Founded
      1970
      Cellectis Nom Eo 05 is listed in the Pharmaceutical Preparations sector of the Euronext with ticker ALCLS. The last closing price for Cellectis Nom Eo 05 was 2.02 €. Over the last year, Cellectis Nom Eo 05 shares have traded in a share price range of 0.888 € to 3.44 €.

      Cellectis Nom Eo 05 currently has 45,874,895 shares outstanding. The market capitalization of Cellectis Nom Eo 05 is 92.67 € million. Cellectis Nom Eo 05 has a price to earnings ratio (PE ratio) of -1.15.

      ALCLS Latest News

      More News

      Cellectis nomme le docteur Adrian Kilcoyne directeur médical

      Cellectis nomme le docteur Adrian Kilcoyne directeur médical NEW YORK, 07 août 2024 (GLOBE NEWSWIRE) -- Cellectis (Euronext Growth : ALCLS ; Nasdaq : CLLS), société de biotechnologie de...

      August 07 2024
      UK Regulatory

      Cellectis Appoints Dr. Adrian Kilcoyne as Chief Medical Officer

      Cellectis Appoints Dr. Adrian Kilcoyne as Chief Medical Officer NEW YORK, Aug. 07, 2024 (GLOBE NEWSWIRE) -- Cellectis (the “Company”) (Euronext Growth: ALCLS - NASDAQ: CLLS), a clinical-stage...

      August 07 2024
      UK Regulatory

      Cellectis Appoints Dr. Adrian Kilcoyne as Chief Medical Officer

      NEW YORK, Aug. 07, 2024 (GLOBE NEWSWIRE) -- Cellectis (the “Company”) (Euronext Growth: ALCLS - NASDAQ: CLLS), a clinical-stage biotechnology company using its pioneering gene-editing platform...

      August 07 2024
      GlobeNewswire Inc.

      Cellectis publie ses résultats financiers du deuxième trimestre 2024

      Cellectis publie ses résultats financiers du deuxième trimestre 2024 Statuts de médicament orphelin et de médicament pour une maladie pédiatrique rare accordés par la FDA et statut de médicament...

      August 06 2024
      UK Regulatory

      Cellectis Provides Financial Results for the Second Quarter 2024

      Cellectis Provides Financial Results for the Second Quarter 2024 ODD and RPDD granted by the FDA and ODD granted by the European Commission to UCART22 for the treatment of ALLODD granted by the...

      August 06 2024
      UK Regulatory

      Cellectis Provides Financial Results for the Second Quarter 2024

      ODD and RPDD granted by the FDA and ODD granted by the European Commission to UCART22 for the treatment of ALLODD granted by the FDA to CLLS52 (alemtuzumab) for ALL treatmentCash position of $273...

      August 06 2024
      GlobeNewswire Inc.

      Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social

      Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social (Article 223-16 du Règlement Général de l’Autorité des Marchés Financiers) PARIS, 05...

      August 05 2024
      UK Regulatory

      Monthly information on share capital and company voting rights

      Monthly information on share capital and company voting rights (Article 223-16 of General Regulation of the French financial markets authority) PARIS, Aug. 05, 2024 (GLOBE NEWSWIRE) -- Listing...

      August 05 2024
      UK Regulatory

      FDA Grants Orphan Drug Designation to Cellectis’ CLLS52 (alemtuzumab) For ALL Treatment

      FDA Grants Orphan Drug Designation to Cellectis’ CLLS52 (alemtuzumab) For ALL Treatment NEW YORK, Aug. 01, 2024 (GLOBE NEWSWIRE) -- Cellectis (the “Company”) (Euronext Growth: ALCLS - NASDAQ: ...

      August 01 2024
      UK Regulatory

      FDA Grants Orphan Drug Designation to Cellectis’ CLLS52 (alemtuzumab) For ALL Treatment

      NEW YORK, Aug. 01, 2024 (GLOBE NEWSWIRE) -- Cellectis (the “Company”) (Euronext Growth: ALCLS - NASDAQ:  CLLS), a clinical-stage biotechnology company using its pioneering gene-editing platform...

      August 01 2024
      GlobeNewswire Inc.
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      10.2211.95652173911.842.1151.804578501.99258267DE
      40.06322.1151.726581311.95401554DE
      12-0.39-15.91836734692.452.551.634748681.93219449DE
      26-0.504-19.65678627152.5643.0251.634834502.2925185DE
      520.2312.56830601091.833.440.8881748492.47263849DE
      156-8.77-80.978762696210.8313.220.8881665293.33944341DE
      260-9.47-82.133564614111.5328.150.8881412306.81372182DE

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      REDReditus SGPS SA
      0.0805 €
      (34.17%)
      		242.96k
      MLCLPColipays
      1.13 €
      (29.89%)
      		20
      ALGLDGold By Gold
      2.78 €
      (24.11%)
      		13.04k
      ALSRSSirius Media
      0.074 €
      (23.33%)
      		3M
      ALDVAlliance Developpement Capital Siic
      0.0745 €
      (22.13%)
      		10k
      ALPHAPharnext
      0.0001 €
      (-50.00%)
      		3.51M
      OXUROxurion NV
      0.0001 €
      (-50.00%)
      		75.87M
      MLIDSIds
      0.352 €
      (-29.60%)
      		3k
      MLMGLAction Magillem Design Services
      3.26 €
      (-22.38%)
      		253
      ALCBICrypto Blockchain Industries
      0.286 €
      (-12.00%)
      		111.89k
      ALSAFSAFE
      0.0002 €
      (0.00%)
      		178.54M
      ALNEVNeovacs
      0.0016 €
      (0.00%)
      		88.76M
      OXUROxurion NV
      0.0001 €
      (-50.00%)
      		75.87M
      BCPBanco Comercial Portugues SA
      0.4044 €
      (1.43%)
      		68.54M
      ALDRVDrone Volt
      0.0048 €
      (4.35%)
      		29.34M

      Discussion

      View Full Feed
      train21 train21 1 minute ago
      THATS WHY THE RUNS HAVE BEEN UNSPECTACULAR AS OF LATE
      TOO MANY SHARES NOT ENOUGH NEW ZILLAs BUYERS
      OLD ZILLAs ONLY BUY AT 0008---0012
      GOT TO HAVE PEOPLE BUYING ALL THE WAY TO COPPER ????? THATS HOW A STOCK GETS TO PENNYLAND
      YOU ALREADY KNOW ALL THAT
      DPLS
      Topgun21 Topgun21 2 minutes ago
      This is going to go NORTHWARD in a HUGE WAY!
      $AGBA BILLIONAIRES, and the BIGGEST FIGHTER OF UFC AND WORLD CHAMP CONNOR has ownership in BKFC!

      That’s growing leaps and bounds!
      Talk about “ground floor entry” along with the 1 share for 1.24 forward split you alluded your e
      AGBA
      dennisdave dennisdave 2 minutes ago
      I'd be happy with $2-3 after approval (I'm still being optimistic).
      me too over the moon happy. Sold at $2
      NWBO
      Zorax Zorax 3 minutes ago
      Actually, she's not making sense, so it's a wasted ego podcast.
      Just wants to see herself and make a few pennies.
      Seminole Red Seminole Red 4 minutes ago
      good story
      Nemesis18 Nemesis18 4 minutes ago
      Treat yourself to a bit of punctuation next time please. ☝️
      NWBO
      bbotcs bbotcs 5 minutes ago
      Gmenfan: We cannot have election integrity in an election that has massive mail-in balloting.
      There is no way in "h" that all of the signatures canbe verified. The RHINO's in Congress don't care, pure and simple.
      Otherwise, they would have started working to limit mail-in balloting a
      Zorax Zorax 6 minutes ago
      What I don't understand is do these car bloggers understand how stupidly UGLY they look in extreme wide phone cam and that people click off them just as fast because of it?
      When did ugly and pig looking get standard optics and the influencer accepted this?

      Sorry, photog take ob
      familyof5 familyof5 7 minutes ago
      in·tu·i·tion.....AKA Paying Attention.....



      in·tu·i·tion
      /?into?o'iSH(?)n,?int?'wiSH(?)n/
      noun


      * the ability to understand something immediately, without the need for conscious reasoning.
      "we shall allow our intuition
      RDGL
      Aero-man Aero-man 8 minutes ago
      Looks like board whack-jobs, docsetc, jerk-n-hard & squidster, have taken some kind of a bung-hole ream-job in one of their dim, dark past scams and now we have to listen to their butt-hurt blather - this is just sad/irritating. Move on whack-jobs, you accomplish ZERO here.
      HALB
      gp22 gp22 8 minutes ago
      R/S opens Mon.: TOVX @ $3.50. Has $16.50 cash. Total shares count 990K.

      This one has strong potential next week.....Reverse Splits have been very hot and TOVX may be in big demand...99.99% of investors have no idea TOVX is going to R/S on Monday.

      This board knows now. I
      TOVX
      train21 train21 8 minutes ago
      I blame the $SEC AND $FINRA BECAUSE THEIR JOB AS A GOVERNMENT AGENCY IS TO PROTECT THE TAX PAYER FROM CROOKS EVEN IF THE TAXPAYER IS STUPID AS YOU BELIEVE
      WHAT THE $SEC SHOULD HAVE DONE IS GIVE HIM A WRITTEN REPREMAND AND THEN MAKE NIXON STEP AWAY AFTER HE FINDS A NEW CEO
      IF
      FINRA SEC
      jay14 jay14 9 minutes ago
      Scroll down to

      Did You Know?

      https://fargoinc.com/susan-bala-fashion-furlongs-film/

      Could the technology be TMMI or
      her other company Phoenix Global Technology
      or both????

      Two years earlier....

      https://www
      TMMI
      AAPL31415926 AAPL31415926 9 minutes ago
      If you read the post I was responding to you’ll actually learn something.
      NWBO
      sharing4u sharing4u 11 minutes ago
      Please look at SPZI with an open mind, pros and cons, possible future success or failure.

      Let me clear this question before going further;

      Was JP Energy Partner LP(JPEP) related to ACP( Arclight Capital Partners LLC) at inception in Texas by Jason Patrick Barley in 2010
      SPZI
      joe botts joe botts 14 minutes ago
      Yes i clock in 7am tomorrow, I make my living posting here.. you got me!!
      Shawonsarker84 Shawonsarker84 15 minutes ago
      I am going to cry lol
      KYNC
      4retire 4retire 15 minutes ago
      What the article didn’t say was the exponential growth in revenues/profits that is now in its second year. This isn’t priced as a value stock, it’s a growth stock, The article didn’t make that differentiation.

      NVDA is becoming a cash cow. Profits are in the 70% range and they reinve
      NVDA
      rouge Vaughn rouge Vaughn 16 minutes ago
      asts has over 150 shares outstanding but a market cap of 4 billion currently
      they got news with at&t with satellite and they took off in may and been up ever since
      same happened with rklb, both in the space sector both took off... especially asts, that one took off and stayed on the
      MNTS
      shrub shrub 16 minutes ago
      BIOA-B.ST started trading in 2017 on the SEK. Nothing to do with BIOA.
      Zorax Zorax 17 minutes ago
      I've noticed that 💩 is momentarily available in reactions if clicking on new member and such. I would submit that the omitting fix is still propagating through the site? It's like a last chance to use 💩 there because to advance to next, clears it out of your list.
      No going bac

      Your Recent History

      EU
      ALCLS
      Cellectis Nom Eo 05
      LSE
      ZL45
      Atlas 2021-1 58
      Delayed Upgrade Clock